"Urologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY TRACT in either the male or the female.
| Descriptor ID |
D014571
|
| MeSH Number(s) |
C04.588.945.947 C12.758.820 C13.351.937.820
|
| Concept/Terms |
Urologic Neoplasms- Urologic Neoplasms
- Urological Neoplasms
- Neoplasm, Urological
- Neoplasms, Urological
- Urological Neoplasm
- Urinary Tract Neoplasms
- Neoplasm, Urinary Tract
- Neoplasms, Urinary Tract
- Tract Neoplasm, Urinary
- Tract Neoplasms, Urinary
- Urinary Tract Neoplasm
- Neoplasms, Urologic
- Neoplasm, Urologic
- Urologic Neoplasm
Cancer of Urinary Tract- Cancer of Urinary Tract
- Urinary Tract Cancers
- Urological Cancer
- Cancer, Urological
- Cancers, Urological
- Urological Cancers
- Cancer of the Urinary Tract
- Urinary Tract Cancer
- Cancer, Urinary Tract
- Cancers, Urinary Tract
- Urologic Cancer
- Cancer, Urologic
- Cancers, Urologic
- Urologic Cancers
|
Below are MeSH descriptors whose meaning is more general than "Urologic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urologic Neoplasms".
This graph shows the total number of publications written about "Urologic Neoplasms" by people in this website by year, and whether "Urologic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 1 | 3 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 0 | 3 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 1 | 2 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urologic Neoplasms" by people in Profiles.
-
Appearance of the Upper Urinary System After Treatment. Urol Clin North Am. 2025 Feb; 52(1):139-152.
-
Novel therapeutic regimens in previously untreated metastatic urothelial carcinoma: A systematic review and bayesian network meta-analysis. Urol Oncol. 2024 11; 42(11):361-369.
-
STAT3 Contributes a Favorable Response to Pembrolizumab Through IFN-?-induced Apoptosis in Urothelial Cancer. Anticancer Res. 2024 May; 44(5):1925-1930.
-
Circulating and urinary tumour DNA in urothelial carcinoma?- upper tract, lower tract and metastatic disease. Nat Rev Urol. 2023 07; 20(7):406-419.
-
Managing adult patients with infectious diseases in emergency departments: international ID-IRI study. J Chemother. 2021 Sep; 33(5):302-318.
-
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma. Cancer Chemother Pharmacol. 2021 06; 87(6):799-805.
-
Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab. Cancer Immunol Immunother. 2021 Mar; 70(3):657-665.
-
COVID-19 and Bacillus Calmette-Gu?rin: What is the Link? Eur Urol Oncol. 2020 06; 3(3):259-261.
-
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Cancer. 2020 03 15; 126(6):1208-1216.
-
Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need. Curr Treat Options Oncol. 2019 04 01; 20(5):40.